The North America GMP testing service market is expected to grow from US$ 846.02 million in 2022 to US$ 1,260.96 million by 2028; it is estimated to grow at a CAGR of 6.9% from 2022 to 2028.
The North America GMP testing service market, by country, is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.
Eurofins Scientific; Almac Group; INTERTEK GROUP PLC; WuXi AppTec; Sartorius AG; North American Science Associates, Inc.; Nelson Laboratories, LLC.; Boston Analytical; Pace Analytical Services; and Thermo Fisher Scientific Inc. (PPD Inc.) are among the leading companies operating in the North America GMP testing service market.
Flourishment of Medical Device Industry Bolsters North America GMP Testing Service Market Growth
The medical devices industry is contributing to the development of medical technologies that have the potential to reinforce the diagnosis and treatment of various illnesses and support the effective manufacturing of medical devices. The equipment produced by the medical devices industry range from common supplies such as surgical masks to high-tech imaging equipment. Medical devices such as insulin delivery systems, glucose monitors, oxygen concentrators, and nebulizers are increasingly being used for the at-home diagnosis and treatment of a few medical disorders. These devices are integrated with the patient’s EMR, wearables, cellphones, and telehealth platforms to provide critical insights for enhanced clinical and operational decision-making. According to data provided by PRODSMART, the medical devices manufacturing industry was valued at ~US$ 4.2 billion in 2020. A rise in the incidence of chronic diseases and the growth of the geriatric population are the major factors that are expected to influence the progress of the medical device industry in the coming years. The operations of medical devices with Internet of Medical Things (IoMT) systems are facilitated by smart gadgets, smart sensors, and other lightweight communication devices. Such innovations assist healthcare companies in improving patient outcomes, lowering costs, and increasing efficiency. The GMPs are enormously important in the manufacturing of medical devices because they ensure a level of quality, safety, purity, and strength in any products that are released to the public. Adhering to these practices helps manufacturers in preventing adverse effects, product recalls, and defects, which may lead to costly liability lawsuits in the future. As quality control and consistent testing environments are pivotal for a successful manufacturing cycle, the focus on GMPs is increasing for avoiding product contamination, failure, and quality deviation. Thus, by establishing a strong system of well-regulated operational management led by GMPs, a medical device manufacturer can develop vast volumes of quality products, along with reducing costly delays. Thus, the above-mentioned factors are bolstering the growth of North America GMP testing service market .North America GMP Testing Service Market Overview
The North America GMP testing service market is segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2021. The growing pharmaceutical industry, and the increasing need for developing novel drugs and medical devices are accelerating the growth of the GMP testing service market in North America. Moreover, the rising health expenditure by governments and an increase in outsourcing activities for the quality assurance of medical products are propelling the expansion of this market in this region. The US holds a significant share of the North America GMP testing service market. The market growth in this country is attributed to rising healthcare expenditure by the government, ongoing developments in the pharmaceuticals industry, and rising demand for novel drugs owing to various infectious diseases.North America GMP Testing Service Market Segmentation
The North America GMP testing service market is segmented on the basis of service type, end user, and country. Based on service type, the market is segmented into product validation testing, bioanalytical services, packaging & shelf life testing, and other services type. The product validation testing segment held the largest market share in 2022.- Based on end user, the North America GMP testing service market is bifurcated into pharmaceutical and biopharmaceutical companies, and medical device companies. The pharmaceutical and biopharmaceutical companies segment held a larger market share in 2022.
The North America GMP testing service market, by country, is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.
Eurofins Scientific; Almac Group; INTERTEK GROUP PLC; WuXi AppTec; Sartorius AG; North American Science Associates, Inc.; Nelson Laboratories, LLC.; Boston Analytical; Pace Analytical Services; and Thermo Fisher Scientific Inc. (PPD Inc.) are among the leading companies operating in the North America GMP testing service market.
Table of Contents
1. Introduction1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Needle Free Injection Systems Market - By Product
1.3.2 North America Needle Free Injection Systems Market - By Technology
1.3.3 North America Needle Free Injection Systems Market - By Type
1.3.4 North America Needle Free Injection Systems Market - By Usability
1.3.5 North America Needle Free Injection Systems Market - By Site of Delivery
1.3.6 North America Needle Free Injection Systems Market - By Application
1.3.7 North America Needle Free Injection Systems Market - By End User
1.3.8 North America Needle Free Injection Systems Market - By Country
2. North America Needle Free Injection Systems Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Needle Free Injection Systems Market - Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Needle Free Injection Systems Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Advantages of Using Self-injection Devices
5.2 Market Restraints
5.2.1 Higher Development Costs of Needle Free Injectors Compared to Conventional Injection Systems
5.3 Market Opportunities
5.3.1 Rising Demand for Vaccines and Biosimilars
5.4 Future Trends
5.4.1 Surge in New Technologies for Needle Free Injection System
5.5 Impact Analysis
6. Needle Free Injection System Market - North America Analysis
6.1 North America Needle Free Injection System Marker Revenue Forecast and Analysis
7. Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Product
7.1 Overview
7.2 North America Needle Free Injection Systems Market, By Product 2022 & 2028 (%)
7.3 Fillable Needle Free Injectors
7.3.1 Overview
7.3.2 Fillable Needle Free Injectors: Revenue and Forecast to 2028 (US$ Thousand)
7.4 Prefilled Needle Free Injectors
7.4.1 Overview
7.4.2 Prefilled Needle Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8. Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Technology
8.1 Overview
8.2 North America Needle Free Injection Systems Market, By Technology 2022 & 2028 (%)
8.3 Jet-Based Needle-Free Injectors
8.3.1 Overview
8.3.2 Jet-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8.4 Spring-Based Needle-Free Injectors
8.4.1 Overview
8.4.2 Spring-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8.5 Microarray Patch Injectors
8.5.1 Overview
8.5.2 Microarray Patch Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8.6 Others
8.6.1 Overview
8.6.2 Others - Revenue and Forecast to 2028 (US$ Thousand)
9. Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Type
9.1 Overview
9.2 North America Needle Free Injection Systems Market, By Type 2022 & 2028 (%)
9.3 Liquid-Based Needle-Free Injectors
9.3.1 Overview
9.3.2 Liquid-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
9.4 Projectile-Based Needle-Free Injectors
9.4.1 Overview
9.4.2 Projectile-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
9.5 Powder-Based Needle-Free Injectors
9.5.1 Overview
9.5.2 Powder-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
10. North America Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Usability
10.1 Overview
10.2 North America Needle Free Injection Systems Market, By Usability 2022 & 2028 (%)
10.3 Disposable
10.3.1 Overview
10.3.2 Disposable - Revenue and Forecast to 2028 (US$ Thousand)
10.4 Reusable
10.4.1 Overview
10.4.2 Reusable - Revenue and Forecast to 2028 (US$ Thousand)
11. North America Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Site of Delivery
11.1 Overview
11.2 North America Needle Free Injection Systems Market, By Site of Delivery 2022 & 2028 (%)
11.3 Subcutaneous Injectors
11.3.1 Overview
11.3.2 Subcutaneous Injectors - Revenue and Forecast to 2028 (US$ Thousand)
11.4 Intramuscular Injectors
11.4.1 Overview
11.4.2 Intramuscular Injectors - Revenue and Forecast to 2028 (US$ Thousand)
11.5 Intradermal Injectors
11.5.1 Overview
11.5.2 Intradermal Injectors - Revenue and Forecast to 2028 (US$ Thousand)
12. North America Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Application
12.1 Overview
12.2 North America Needle Free Injection Systems Market, By Application 2022 & 2028 (%)
12.3 Vaccine Delivery
12.3.1 Overview
12.3.2 Vaccine Delivery - Market Revenue and Forecast to 2028 (US$ Thousand)
12.4 Insulin Delivery
12.4.1 Overview
12.4.2 Insulin Delivery - Market Revenue and Forecast to 2028 (US$ Thousand)
12.5 Pain Management
12.5.1 Overview
12.5.2 Pain Management - Market Revenue and Forecast to 2028 (US$ Thousand)
12.6 Oncology
12.6.1 Overview
12.6.2 Oncology - Market Revenue and Forecast to 2028 (US$ Thousand)
12.7 Dermatology
12.7.1 Overview
12.7.2 Dermatology - Market Revenue and Forecast to 2028 (US$ Thousand)
12.8 Others
12.8.1 Overview
12.8.2 Others - Market Revenue and Forecast to 2028 (US$ Thousand)
13. North America Needle Free Injection Systems Market Analysis- By End User
13.1 Overview
13.2 North America Needle Free Injection Systems Market, By End User 2022 & 2028 (%)
13.3 Pharmaceutical and Biotechnology Companies
13.3.1 Overview
13.3.2 Pharmaceutical and Biotechnology Companies - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.4 Hospitals
13.4.1 Overview
13.4.2 Hospitals - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.5 Research Laboratories
13.5.1 Overview
13.5.2 Research Laboratories - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.6 Home Care Settings
13.6.1 Overview
13.6.2 Home Care Settings - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.7 Other End User
13.7.1 Overview
13.7.2 Other End User - Market Revenue and Forecasts To 2028 (US$ Thousand)
14. North America Needle Free Injection Systems Market Revenue and Forecasts to 2028 - Country Analysis
14.1 Overview
14.1.1 North America: Needle Free Injection System Market, by Country, 2022 & 2028 (%)
14.1.1.1 US: Needle Free Injection System Market- Revenue and Forecast to 2028 (USD Thousands)
14.1.1.1.1 US: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousands)
14.1.1.1.2 US: Needle Free Injection System Market, by Product, 2019-2028 (USD Thousands)
14.1.1.1.3 US: Needle Free Injection System Market, by Technology, 2019-2028 (USD Thousands)
14.1.1.1.4 US: Needle Free Injection System Market, by Type, 2019-2028 (USD Thousands)
14.1.1.1.5 US: Needle Free Injection System Market, by Usability, 2019-2028 (USD Thousands)
14.1.1.1.6 US: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (USD Thousands)
14.1.1.1.7 US: Needle Free Injection System Market, by Application, 2019-2028 (USD Thousands)
14.1.1.1.8 US: Needle Free Injection System Market, by End User, 2019-2028 (USD Thousands)
14.1.1.2 Canada: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousands)
14.1.1.2.1 Canada: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousands)
14.1.1.2.2 Canada: Needle Free Injection System Market, by Product, 2019-2028 (USD Thousands)
14.1.1.2.3 Canada: Needle Free Injection System Market, by Technology, 2019-2028 (USD Thousands)
14.1.1.2.4 Canada: Needle Free Injection System Market, by Type, 2019-2028 (USD Thousands)
14.1.1.2.5 Canada: Needle Free Injection System Market, by Usability, 2019-2028 (USD Thousands)
14.1.1.2.6 Canada: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (USD Thousands)
14.1.1.2.7 Canada: Needle Free Injection System Market, by Application, 2019-2028 (USD Thousands)
14.1.1.2.8 Canada: Needle Free Injection System Market, by End User, 2019-2028 (USD Thousands)
14.1.1.3 Mexico: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousands)
14.1.1.3.1 Mexico: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousands)
14.1.1.3.2 Mexico: Needle Free Injection System Market, by Product, 2019-2028 (USD Thousands)
14.1.1.3.3 Mexico: Needle Free Injection System Market, by Technology, 2019-2028 (USD Thousands)
14.1.1.3.4 Mexico: Needle Free Injection System Market, by Type, 2019-2028 (USD Thousands)
14.1.1.3.5 Mexico: Needle Free Injection System Market, by Usability, 2019-2028 (USD Thousands)
14.1.1.3.6 Mexico: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (USD Thousands)
14.1.1.3.7 Mexico: Needle Free Injection System Market, by Application, 2019-2028 (USD Thousands)
14.1.1.3.8 Mexico: Needle Free Injection System Market, by End User, 2019-2028 (USD Thousands)
15. Needle-Free Injection System Market-Industry Landscape
15.1 Overview
15.2 Growth Strategies Done by the Companies in the Market (%)
15.3 Organic Developments
15.3.1 Overview
15.4 Inorganic Developments
15.4.1 Overview
16. Company Profiles
16.1 Crossject
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 INOVIO Pharmaceuticals
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Zealand Pharma A/S
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 PharmaJet
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Portal Instruments
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Medical International Technologies (MIT Canada) Inc.
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 NuGen Medical Devices
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Ferring B.V.
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 National Medical Products, Inc.
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Aijex Pharma International Inc.
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
17. Appendix
17.1 About the Publisher
17.2 Glossary of Terms
Table 1. US Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (USD Thousands)
Table 2. US Needle Free Injection System Market, by Technology- Revenue and Forecast to 2028 (USD Thousands)
Table 3. US Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (USD Thousands)
Table 4. US Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (USD Thousands)
Table 5. US Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (USD Thousands)
Table 6. US Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (USD Thousands)
Table 7. US Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (USD Thousands)
Table 8. Canada Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (USD Thousands)
Table 9. Canada Needle Free Injection System Market, by Technology- Revenue and Forecast to 2028 (USD Thousands)
Table 10. Canada Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (USD Thousands)
Table 11. Canada Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (USD Thousands)
Table 12. Canada Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (USD Thousands)
Table 13. Canada Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (USD Thousands)
Table 14. Canada Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (USD Thousands)
Table 15. Mexico Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (USD Thousands)
Table 16. Mexico Needle Free Injection System Market, by Technology- Revenue and Forecast to 2028 (USD Thousands)
Table 17. Mexico Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (USD Thousands)
Table 18. Mexico Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (USD Thousands)
Table 19. Mexico Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (USD Thousands)
Table 20. Mexico Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (USD Thousands)
Table 21. Mexico Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (USD Thousands)
Table 22. Organic Developments Done by Companies
Table 23. Inorganic Developments Done by Companies
Table 24. Glossary of Terms
Figure 1. North America Needle Free Injection Systems Market Segmentation
Figure 2. North America Needle Free Injection Systems Market, By Country
Figure 3. North America Needle Free Injection Systems Market Overview
Figure 4. Fillable Needle-Free Injectors Segment Held Largest Share of Product Segment in North America Needle Free Injection Systems Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. North America Needle Free Injection Systems Market Impact Analysis of Driver and Restraints
Figure 8. North America Needle Free Injection System Market - Revenue Forecast and Analysis - 2019-2028
Figure 9. North America Needle Free Injection Systems Market, by Product 2022 & 2028 (%)
Figure 10. Fillable Needle Free Injectors: Revenue and Forecasts to 2028 (US$ Thousand)
Figure 11. Prefilled Needle Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 12. North America Needle Free Injection Systems Market, by Technology 2022 & 2028 (%)
Figure 13. Jet-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 14. Spring-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 15. Microarray Patch Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 16. Others - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 17. North America Needle Free Injection Systems Market, by Type 2022 & 2028 (%)
Figure 18. Liquid-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 19. Projectile-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 20. Powder-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 21. North America Needle Free Injection Systems Market, by Usability 2022 & 2028 (%)
Figure 22. Disposable - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 23. Reusable - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 24. North America Needle Free Injection Systems Market, by Site of Delivery 2022 & 2028 (%)
Figure 25. Subcutaneous Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 26. Intramuscular Injector - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 27. Intradermal Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 28. North America Needle Free Injection Systems Market, by Application 2022 & 2028 (%)
Figure 29. Vaccine Delivery - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 30. Insulin Delivery - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 31. Pain Management - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 32. Oncology - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 33. Dermatology - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 34. Others - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 35. North America Needle Free Injection Systems Market, by End User 2022 & 2028 (%)
Figure 36. Pharmaceutical and Biotechnology Companies - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 37. Hospitals - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 38. Research Laboratories - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 39. Home Care Settings - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 40. Other End User - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 41. North America: Needle Free Injection System Market, by Key Country - Revenue (2022) (USD Thousands)
Figure 42. North America: Needle Free Injection System Market, by Country, 2022 & 2028 (%)
Figure 43. US: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousands)
Figure 44. Canada: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousands)
Figure 45. Mexico: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousands)
Figure 46. Growth Strategies Done by the Companies in the Market (%)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aijex Pharma International Inc.
- Crossject
- Ferring B.V.
- Medical International Technologies (MIT Canada) Inc.
- National Medical Products, Inc.
- NOVIO Pharmaceuticals
- NuGen Medical Devices
- PharmaJet
- Portal Instruments
- Zealand Pharma A/S
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 161 |
| Published | January 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 846.02 Million |
| Forecasted Market Value ( USD | $ 1260.96 Million |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | North America |
